https://observatoiredumedicament.cyrilcoquilleau.com/medicament/irinotecan-accord-20-mgml--65484054
IRINOTECAN ACCORD 20 mg/mL : Informations sur le médicament – L'observatoire du médicament
Informations sur le médicament : exploitant, composition, dates de commercialisation, indications thérapeuthiques, conditionnements commercialisés, évolution...
irinotecanaccordinformationssurobservatoire
https://kanker-actueel.nl/chemo-en-alvleesklierkanker-gemcitabine-to-combinatie-folfirinox-5-fluorouracil-leucovorin-irinotecan-en-oxaliplatine-geeft-geen-enkele-meerwaarde-op-ziektevrije-tijd-en-overall-overleving-bij-operabele-alvleesklierkanker.html
Gemcitabine t.o. combinatie FOLFIRINOX (5-fluorouracil, leucovorin, irinotecan, en oxaliplatine)...
Gemcitabine t.o. combinatie FOLFIRINOX (5-fluorouracil, leucovorin, irinotecan, en oxaliplatine) geeft geen enkele meerwaarde op ziektevrije tijd en overall...
t ogemcitabinecombinatiefolfirinoxfluorouracil
https://adisinsight.springer.com/drugsafety/803915445?error=cookies_not_supported&code=2467a328-83ad-4863-a69b-bb69d8cfd183
Fluorouracil/Irinotecan/Rucaparib - AdisInsight
In a phase 1 study, 18 patients with metastatic gastrointestinal cancers who had previously progressed on at least one systemic therapy received a combination
fluorouracilirinotecanrucaparib
https://unilexicon.com/med/35612411000001101
Irinotecan 220mg/250ml in Sodium chloride 0.9% infusion bags - Unilexicon for medicines
sodium chlorideinfusion bagsirinotecanmedicines
https://mdanderson.elsevierpure.com/en/publications/tyrosine-kinase-inhibitor-enhances-the-bioavailability-of-oral-ir/
Tyrosine kinase inhibitor enhances the bioavailability of oral irinotecan in pediatric patients...
tyrosine kinase inhibitorenhancesbioavailabilityoralirinotecan
https://australiancancertrials.gov.au/glossary/irinotecan-camptosar/
Irinotecan (Camptosar) - Clinical Trials Search
A chemotherapy drug used in the treatment of colorectal cancer.
clinical trials searchirinotecancamptosar
https://zuyderland.nl/specialismen/oncologischezorg/oncologisch-dagcentrum/bijwerking-diarree/diarree-bij-campto/
Zuyderland | Diarree bij Irinotecan / Campto - Zuyderland
diarreebijirinotecan
https://www.vidal.fr/medicaments/gammes/irinotecan-arrow-74200.html
IRINOTECAN ARROW
irinotecanarrow
https://scholars.uthscsa.edu/en/publications/altered-irinotecan-and-sn-38-disposition-after-intravenous-and-or/fingerprints/
Altered irinotecan and SN-38 disposition after intravenous and oral administration of irinotecan in...
oral administrationalteredirinotecandispositionintravenous
https://www.hod.care/test/ugt1a1-gene-polymorphism-irinotecan-dosage
UGT1A1 Gene Polymorphism (Irinotecan Dosage) | HOD
gene polymorphismirinotecandosagehod
https://researchinformation.umcutrecht.nl/en/publications/phase-i-dose-escalation-study-combining-irinotecan-loaded-drug-el/
Phase I Dose-Escalation Study Combining Irinotecan-Loaded Drug-Eluting Bead Chemoembolization with...
phase idoseescalationstudycombining
https://www.everydayhealth.com/drugs-supplements/irinotecan/
Irinotecan (Camptosar) - Side Effects, Interactions, Uses, Dosage, Warnings
Apr 13, 2021 - Find everything you need to know about Irinotecan (Camptosar), including what it is used for, warnings, reviews, side effects, and interactions. Learn more...
side effectsirinotecancamptosarinteractionsuses
https://www.patlynk.com/trial/NCT00004924
Phase II Trial of Irinotecan Plus Paclitaxel in Patients With Advanced Nonsmall Cell Lung Cancer |...
OBJECTIVES: Determine the antitumor activity and toxicities of irinotecan and paclitaxel in patients with advanced non-small cell lung cancer. OUTLINE: Patie
phase ii triallung canceririnotecanpluspaclitaxel
https://arpi.unipi.it/handle/11568/105221
The triplet combination of irinotecan, oxaliplatin and 5FU/LV (FOLFOXIRI) vs the doublet of...
tripletcombinationirinotecanoxaliplatinfolfoxiri
https://www.mskcc.org/cancer-care/clinical-trials/26-243
A Study of MOMA-341 Alone or in Combination With Irinotecan or Pembrolizumab in People With Solid...
Full Title A Phase 1 Study of MOMA-341 as Monotherapy or Combination Therapy in Participants with Advanced or Metastatic Solid Tumors Purpose To learn more...
a studymomaalonecombinationirinotecan